Article ID Journal Published Year Pages File Type
8439594 European Journal of Cancer 2018 12 Pages PDF
Abstract
EORTC 90101, ClinicalTrials.gov NCT01524926.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial
Authors
, , , , , , , , , , , , , ,